NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
| Website: | www.neogenomics.com |
| Email: | bill.bonello@neogenomics.com |
| Main Phone: | +1 239 768-0600 |
| Address: | 12701 Commonwealth Drive |
| Address 2: | Suite 9 |
| State: | FL |
| City / Town: | Fort Myers |
| Country: | US |
| Postal Code: | 33913 |
| Exchange: | NSC |
| CEO: | Douglas M. VanOort |
| Employees: | 1700 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
Four companies that look strong via technical analysis.
Robotics and artificial intelligence are setting the stage for longer lifespans and new investment opportunities.
Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of
Potential. That's what every investor is looking for in a biotech investment. Grant Zeng of Zacks Small-Cap Research zeroes in on three primary factors when he looks at whether a particular
Shares for Sears Holdings Corp. (SHLD) plummeted some 13.4 percent on Friday, after dropping some 12.4 in early trading, a response to the dismal earnings report the company released late the
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
| Website: | www.neogenomics.com |
| Email: | bill.bonello@neogenomics.com |
| Main Phone: | +1 239 768-0600 |
| Address: | 12701 Commonwealth Drive |
| Address 2: | Suite 9 |
| State: | FL |
| City / Town: | Fort Myers |
| Country: | US |
| Postal Code: | 33913 |
| Exchange: | NSC |
| CEO: | Douglas M. VanOort |
| Employees: | 1700 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
Four companies that look strong via technical analysis.
Robotics and artificial intelligence are setting the stage for longer lifespans and new investment opportunities.
Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of
Potential. That's what every investor is looking for in a biotech investment. Grant Zeng of Zacks Small-Cap Research zeroes in on three primary factors when he looks at whether a particular
Shares for Sears Holdings Corp. (SHLD) plummeted some 13.4 percent on Friday, after dropping some 12.4 in early trading, a response to the dismal earnings report the company released late the
| Last Price 56.03 | Change $ 0.74 | Change % 1.34 | Tick N/A |
| Bid 56.12 | Bid Size 100.00 | Ask 59.00 | Ask Size 200.00 |
| Open 54.85 | High 56.27 | Low 54.65 | Prev Close 55.29 |
| Last Trade | Volume 716,886 | 52 Wk Hi 57.07 | 52 Wk Low 20.47 |
| Market Cap 6.4 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 115,111,276.00 | EPS (TTM) -0.05 | PE Ratio -1,120.60 | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 32 | 42 |
| Number of Buys | 20 | 26 |
| Number of Sells | 12 | 16 |
| Net Activity | -231499 | -228889 |
| Last 10 Buys | Shares |
|---|---|
| Alison L. Hannah | 1,000 |
| Kevin Johnson | 1,000 |
| Alison L. Hannah | 1,000 |
| Kevin Johnson | 1,000 |
| Lynn A. Tetrault | 1,000 |
| Lynn A. Tetrault | 1,000 |
| Robert J. Shovlin | 1,000 |
| Bruce K. Crowther | 1,000 |
| Maher Albitar | 1,000 |
| Stephen J. Clearman | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Steven C. Jones | 1,000 |
| Steven C. Jones | 1,000 |
| Steven C. Jones | 1,000 |
| Steven C. Jones | 1,000 |
| Jennifer Balliet | 1,000 |
| Jennifer Balliet | 1,000 |
| Jennifer Balliet | 1,000 |
| Jennifer Balliet | 1,000 |
| Steven A. Ross | 1,000 |
| Jennifer Balliet | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 13 | 11 | 11 | 14 |
| Low Target Price Estimate | 10 | 10 | 10 | 10 |
| Mean Target Price Estimate | 11.2 | 10.8 | 10.8 | 11.8 |
| Standard Deviation | 1.1 | 0.45 | 0.45 | 1.64 |
| Date of Most Recent Estimate | 06/04/18 | 05/15/18 | 05/02/18 | 06/07/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 40 | 2018-06-12 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-01 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-31 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.33 | 1.33 | 1.29 | 1.38 |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait